However, no significant correlation has been found between bone marrow CXCL9 levels and blood levels of hemoglobin, calcium, creatinine, B2M, or MM burden in these patients [56], suggesting that CXCL9 may not play a central role in tumorigenic mechanisms within the bone marrow. The gene discussed is CXCL9; the disease is Miyoshi myopathy.